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Abstract Menisci are crucial structures in the knee joint
as they play important functions in load transfer, main-
taining joint stability and in homeostasis of articular car-
tilage. Unfortunately, ones of the most frequently occurring
knee injuries are meniscal tears. Particularly tears in the
avascular zone of the meniscus usually do not heal spon-
taneously and lead to pain, swelling and locking of the
knee joint. Eventually, after a (partial) meniscectomy, they
will lead to osteoarthritis. Current treatment modalities to
repair tears and by that restore the integrity of the native
meniscus still carry their drawbacks and a new robust
solution is desired. A strong tissue adhesive could provide
such a solution and could potentially improve on sutures,
which are the current gold standard. Moreover, a glue
could serve as a carrier for biological compounds known to
enhance tissue healing. Only few tissue adhesives, e.g.,
Dermabond and fibrin glue, are already successfully used
in clinical practice for other applications, but are not con-
sidered suitable for gluing meniscus tissue due to their sub-
optimal mechanical properties or toxicity. There is a
growing interest and research field focusing on the
development of novel polymer-based tissue adhesives, but
up to now, there is no material specially designed for the
repair of meniscal tears. In this review, we discuss the
current clinical gold standard treatment of meniscal tears
and present an overview of new developments in this field.
Moreover, we discuss the properties of different tissue
adhesives for their potential use in meniscal tear repair.
Finally, we formulate recommendations regarding the
design criteria of material properties and adhesive strength
for clinically applicable glues for meniscal tears.
1 Introduction
Menisci are crescent shaped discs of fibrocartilage with a
triangular cross-section, present in duplicate in each knee
joint. The menisci have been recognized as crucial struc-
tures in maintaining knee joint stability and articular car-
tilage homeostasis [1–3]. During normal functioning, they
are exposed to shear, tension and compression forces and
serve a variety of (bio)mechanical functions, such as load
bearing, constituting contact area, guiding rotation and
stabilizing translation [4–7]. They also play a role in
lubrication and nutrition of the underlying articular carti-
lage surfaces and by that might help to prevent the devel-
opment of osteoarthritis [1].
The most commonly occurring injuries of the knee joint
are meniscus tears. They originate either from acute injuries
of the knee joint (e.g. sport, trauma) or are caused by
degenerative changes (mostly in case of elderly patients)
associated with early osteoarthritis [8]. Irrespective to their
origin, they might cause pain, swelling and locking of the
joint, and they may ultimately lead to osteoarthritis [9].
Therefore, it is of utmost importance to provide an effective
treatment modality and to prevent this negative scenario.
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In the past, it was believed that menisci could be
removed without any immediate or long-term conse-
quences for the function of the knee joint and consequently
a (partial) meniscectomy was performed as a gold standard
treatment. In fact, short-term results were very satisfactory.
It resulted in instant pain relief and restoration of knee
function, but as osteoarthritis develops very slowly, it took
decades to find out that even a partial meniscectomy
inevitably leads to joint degeneration [10, 11]. In 1975
Krause et al. showed that menisci have a function in load-
transmission and stress absorption in the knee and that peak
stresses acting on articular cartilage increase after menis-
cectomy [6]. Removal of only 15–34 % of the meniscus, a
partial meniscectomy, will produce a 350 % increase in
contact stress and lead to development of degenerative
changes and eventually osteoarthritis in a majority of the
patients [12]. Ever since, the preferred strategies aim at
restoration of the integrity of the meniscus rather than at its
removal by (partial) meniscectomy [13]. These treatment
methods can only be effective if the torn parts of the tissue
are kept in close proximity to each other enabling a healing
process to take place. Many devices have been developed
and tested in clinical practice for this purpose, such as
sutures, stingers, staples, arrows and darts [14, 15]. How-
ever, the success rate of these devices highly depend on the
location of the meniscal lesion [16]. They are mainly
effective in treating lesions located in the peripheral vas-
cularized region of the meniscus [17, 18]. Moreover, the
techniques are challenging, surgical procedure is time-
consuming and devices are expensive. Therefore, it would
be ideal to find an alternative treatment method, which
should be easier and faster to perform, and would allow a
more universal successful treatment of tears, also those
located in the avascular region of the meniscus.
Recently, much interest has been paid to tissue adhe-
sives as an alternative to sutures. Tissue adhesives are
already used in clinical practice for other purposes, such as
Dermabond (2-octyl cyanoacrylate) as topical skin
adhesive, fibrin glue for pulmonary leaks, and recently
TissuGlu (an FDA approved urethane-based adhesive) for
abdominoplasty surgery [19, 20]. However, up to now,
there is no clinically available glue suitable for the treat-
ment of meniscal tears.
The purpose of this paper was to summarize current
advances in the development of tissue adhesives, compare
them with the current clinical gold standard treatments and
critically evaluate their potential application in the treatment
of meniscal tears. Mechanical and biological properties of
the meniscus are discussed and requirements for a suit-
able material are formulated. Subsequently, characteristics
of the main groups of tissue adhesives found in literature are
discussed and conclusions and recommendations for future
clinical directions are made.
2 Biology of the meniscus
The healthy meniscus contains 72 % water, the remaining
28 % are organic compounds: 22 % collagen, 0.8 % gly-
cosaminoglycans (GAGs, of which the major part (40 %) is
chondroitin 6-sulphate), DNA (2 %), adhesion glycopro-
teins (\1 %) and elastin (\1 %) [21]. These proportions
may vary depending on age or degenerative status. For
instance, with increasing degeneration the water content
can increase up to 85 % [21] and the cellularity of the
meniscus decreases [22]. The blood supply of the meniscus
is also age dependent: the meniscus of an infant is fully
vascularized, while an adult meniscus is only partly vas-
cularized, i.e. the outer part. An adult meniscus can be
divided into three zones: the outer (red–red), middle (red–
white) and inner (white–white) zone, see Fig. 1, [23–25].
The outer two-thirds of the meniscus (red–red and the red–
white zone) are vascularized, the cells are fibroblast-like
and the collagen fibers present there are mainly type I. The
inner one-third of the meniscus (white–white zone) is
avascular, contains both collagen type I and II and the cells
in this region are more (fibro)chondrocyte-like [26, 27].
Moreover, the inner two thirds of the meniscus contain
more GAGs, whose main function is to enable the menis-
cus to take up water in order to improve their visco-elastic
behaviour and counter compressive loads on the tissue
[23]. Due to differences in the structure of the meniscus,
particularly related to the vascularization and differences in
cell phenotype, tears that occur in the outer red–red part of
the meniscus have the ability for self-repair. Tears in the
middle part are less likely to heal spontaneously, while
tears in the inner white–white part are unable to repair
themselves [28, 29].
3 Biomechanics of the meniscus
The two menisci cover an area of approximately 2/3 of the
tibial plateau [30]. They stabilize the knee, provide con-
gruity and lubrication of the articular cartilage, and con-
stitute a large contact area between tibial plateau and
femoral condyle. The main attachment sites of the medial
and lateral menisci in the joint are the menisco-tibial
ligamental attachments [31]. Additional ligaments are the
transverse ligament and the posterior and anterior menis-
cus-femoral ligaments (Wrisberg and Humphry) [31]. The
medial meniscus is more firmly attached to the joint cap-
sule than the lateral. The lateral meniscus is also more
flexible. Throughout the whole range of flexion and
extension of the knee joint menisci play a crucial role in
transferring loads [32]. They are subjected to tensile,
compressive and shear forces and they are displaced
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radially from the center of femoral condyles due to com-
pressive forces in combination with different flexion angles
of the knee [33, 34]. As a result of the compressive loading
on the meniscus, the stress is transferred to a vertical force,
whose radial component causes a radial displacement of
the meniscus. As the meniscus is firmly connected with the
tibial plateau through its anterior and posterior attach-
ments, its displacement is constrained by the circumpher-
entially orientated collagen bundles resulting in a
circumpherentially directed component of force and tensile
stress (see Fig. 2a), [34]. The collagen fibers in the
meniscus structure are organized in a manner that opti-
mally resists these tensile stresses [35]. The surface layer of
the meniscus contains sheets of radially oriented collagen
fibres, to cope with shear forces, while the deep zone has
circumpherentially organized collagen fibres, to withstand
the circumpherential forces (see Fig. 2b).
Biomechanical properties of meniscal tissue (see Fig. 3)
have been extensively described in literature. Fithian et al.
reported that the tensile modulus measured in circumfer-
ential direction was in the range 100–300 MPa and in
radial direction between 10 and 30 MPa. The shear mod-
ulus of the meniscus was measured to be approximately
120 kPa [35]. Lechner et al. and Tissakht et al. reported a
tensile modulus in circumferential direction ranging from
40 up to 140 MPa [36, 37].
4 Meniscal tears and their healing potential
There are two main causes of meniscus tears: trauma (e.g.
sports injuries) mostly occurring in young and active
patients, and degeneration, which are mainly associated
with early stages of osteoarthritis and are more frequently
observed in elderly patients [38]. An overview of the
classification of meniscal tears is shown in Fig. 4. Longi-
tudinal tears, such as commonly occurring bucket-handle
lesions, are classified as traumatic, whereas flap, horizontal
and tears in menisci with deteriorating changes are classi-
fied as degenerative. Radial tears may be classified both as
traumatic and degenerative [38]. Unfortunately, the tears
are usually located in the highly loaded, avascular, inner
region of the meniscus and do not heal spontaneously.
Moreover, it has been reported that there are significantly
better results after treating traumatic than degenerative
lesions [10]. This is mainly due to the fact that degenera-
tive tears are often associated with early stages of
osteoarthritis and disturbed homeostasis of the knee joint,
thus in this condition it is more difficult to successfully
repair them [39]. The orientation of the tear also influences
its ability to heal. Tears that disrupt the circumpherentially
oriented collagen fibers may be more difficult to heal or do
not heal at all since they interfere with the circumpherential
mechanical properties of the meniscus tissue [40–42].
Thus, longitudinal tears are relatively the easiest to heal
and the native mechanical function will be restored after
healing [29, 43–45]. Therefore, as traumatic lesions are
usually oriented in the circumpherential direction, only in
these cases in young patients, restoration of the native
tissue is the preferred treatment. Elderly patients with
degenerative changes are offered alternative treatment
methods, such as partial meniscectomy [29], allograft
transplantation or implantation of a permanent implant,
however these methods are not covered by this review, and
are widely described elsewhere [46].
5 Current clinical treatment methods of meniscal
tears
There are numerous techniques used in clinical practice to
restore the integrity and function of torn menisci, most
used are sutures, staples, stingers and screws [47]. These
devices are employed to keep the torn meniscus together
Fig. 1 Regional variations in
vascularization and cell
populations of the meniscus,
showing on the left the red–red,
white–red and white–white
regions, and on the right the
differences in cell populations
and the location of the blood
vessels. Reprinted from [23]
(Color figure online)
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enabling tissue healing. Among these techniques, suturing
is superior, since it provides optimal mechanical stability
and has the highest strength at failure [8, 11, 47, 48].
Different suturing techniques are used: all-inside, outside-
in, inside-out, in order to provide the most suitable treat-
ment for particular tears [49]. The use of vertical sutures
provides the best results and is therefore the current gold
standard [50]. An alternative to sutures, which are usually
difficult to apply during minimally invasive surgery as the
procedure is time-consuming and may induce scarring and
cause problems with healing, might be using Meniscus
Arrows or Smart Nails, which are easier to apply [51].
However, they carry the risk of chondral abrasion, due to
the fact that a part of these devices remain exposed at the
surface of the meniscus and harm articular cartilage [52].
In addition, these implants might fail, and as they are
usually prepared from non-degradable materials, articular
cartilage might be damaged due to the long-term presence
of material debris in the knee joint.
In clinical practice, procedures aimed at increasing the
rate of healing in the avascular zone are also proposed.
Rasping the tissue to expose collagen fibers and induce
vascularization, trephination and creation of access chan-
nels to facilitate new tissue ingrowth have been employed
[53–57]. However, the success rate is found to mainly
depend on the type and location of the tear.
6 Advances in research of meniscal tears repair
Recent advances in meniscus research suggest that the low
cellularity, dense ECM and poor vascularity together with
the inflammatory condition of the knee joint in general
might also be responsible for the lack of healing potential.
Reprogramming of the wound environment is one of the
potential targets to increase the healing potential of the
meniscus, but this requires extra steps in treating the tissue
adjacent the tear [58]. Amongst the procedures which were
proposed are the delivery of therapeutics by biomaterial-
based technologies and the partial digestion of the matrix in
the torn region by collagenase which might enable the
migration of cells to the wound margin and stimulate
healing [59, 60]. On the other hand an approach in which
the level of proteolytic enzymes is controlled may also
improve meniscus capacity to repair, as the present
inflammation is associated with increased synovial
inflammation and increased level of the proteolytic
enzymes, especially metalloproteinases (MMP) [61, 62]. In
an in vitro repair and animal models it has been shown that
by introducing inflammatory cytokines, such as inter-
leukin-1, the integration of the meniscus can be reduced,
while inhibiting MMPs and catabolic cytokines can restore
its integration capability [63–65]. Another approach which
was already proven to have a beneficial influence on
meniscal repair is the injection of progenitor cells into the
joint, a procedure which enhances tissue regeneration. Also
growth factors, especially TGF-b, have been shown to
increase proteoglycans synthesis by fibrochondrocytes
from different zones of the meniscus in an in vitro cultures
[66–68]. Further development of these techniques to clin-
ical use could improve the healing capacity of the menis-
cus, potentially making the whole healing process shorter
and more efficient.
Fig. 2 a A schematic representation of the forces acting on the
meniscus. Ff is a joint load on top of the meniscus, Ft is the reaction
force at tibial plateau, radially oriented force Ffh and vertically
oriented Ffv are balanced by forces generated by anterior and posterior
horns Fa and Fp. A combination of these forces results in tensile hoop
stress F and axial and radial components of stress in the meniscus (Fr
and Fc) while loading [34]. b Schematic representation of collagen
fibers alignment in meniscal tissue, reprinted from [145]
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In the light of the complexity of the biological modifi-
cations developed to improve the meniscus repair capacity,
there might also be a great potential in the use of tissue
adhesives. They could serve as an alternative or support for
sutures, and would keep the wound edges of the tear close
to each other. The use of slowly resorbable tissue adhesives
would have numerous advantages, such as easy and fast
application, no need of removal after the tissue is healed,
and at the same time they could act as a carrier to deliver
cells, growth factors, enzymes and other biological factors
to the meniscus. Thus, they could be used in combination
with the treatment modalities described in the previous
section. There already have been attempts in the clinic to
use fibrin gels in meniscus repair treatments, either as a
glue or as a support to suturing [49, 50, 69–72]. More
details of these procedures are given later. However, until
now they have not been adopted in clinical practice. It
remains a challenge to develop a tissue adhesive which has
all the required properties for adequate meniscal tear
repair. In this review we focus on a discussion on the
desired properties of glues for meniscal tear repair and how
current developments in the field comply with them.
7 Requirements of tissue adhesives for use
in meniscal repair
Tissue adhesives are defined as materials capable to attach
and remain on surfaces of biological substrates with ability
to interact with biological factors [73]. Any tissue adhe-
sive, regardless its intended application, should fulfil a
large number of requirements to be suitable for biomedical
use [74]. Most importantly, good attachment to (wet) tissue
surfaces is a prerequisite. The material must be non-cyto-
toxic and not induce any adverse tissue reaction. An
adhesive should initially be in a liquid state with an ade-
quate viscosity to be able to apply it only locally on the
tissue in adequate amounts. There should be no need for
elaborate application techniques or devices, and the adhe-
sive should preferably be injectable. It should wet and
spread over the entire surface of the tissue to be glued,
resulting in effective and close contact between adhesive
molecules and the surface of the tissue. Thereafter, it
should solidify shortly after its application [75]. The
adhesive should achieve a stable union between the tissue
Fig. 3 Overview of the tensile properties of anterior, central and
posterior part of the human medial and lateral meniscus, based on
[35–37]. View on the right knee. E elastic modulus, emax elongation at
maximum applied force, UTS ultimate tensile strength (only in
circumferential direction)
Fig. 4 Classification of meniscal tears. Reprinted from [38]
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surfaces until proper healing has occurred. To allow this, it
must withstand forces present on the site of application.
Finally, it should degrade and potentially be resorbed by
the body so that the two edges of the wound can reunite to
accomplish complete wound healing. Biodegradation
products of the cured tissue adhesives must be not cyto-
toxic and must have sizes allowing their clearance by the
kidney (maximally 50 kDa [76]). Moreover, the tissue
adhesive should be shelf-stable and preferably coloured for
easy visualization [74]. Abovementioned requirements are
critical for every tissue adhesive material, regardless of the
site of application. For materials intended for specific
purposes, additional criteria should be formulated [77].
To formulate specific design criteria for tissue adhesives
for meniscus tear repair, the particularity of the tissue in
terms of its structure, vascularisation, healing potential and
its performance in loaded conditions must be considered.
The adhesive has to spread well on the wet surfaces of the
meniscus in a synovial environment. Subsequently, it
should cure forming a solid network strong enough to
withstand the forces present in the knee joint. Therefore, it
should be sufficiently hydrophilic to facilitate spreading on
the tissue. Secondly, in order to obtain a strong network
after curing, the adhesive should preferably contain
hydrophobic components as well. These components will
contribute to good mechanical properties of the network
after curing. The tensile modulus of the cured network
should be in the same range as that of meniscus tissue in
the circumferential direction, as the majority of injuries
fitting criteria for repair occur in the circumferential
direction [78]. This means that it should be in the range of
values between 40 and 150 MPa (see Fig. 3). The ultimate
tensile strength (UTS) of the adhesive should be either
higher or comparable to that of meniscus tissue, which is
approximately between 12 and 19 MPa in circumferential
direction (see Fig. 3).
When designing the degradation profile of the adhesive,
the healing rate of the meniscus must be taken into account.
In general, patients are advised to use crutches for
8–10 weeks post-surgery after repair of a meniscal tear
using sutures to avoid overloading the meniscus tissue
during its healing process [29]. At the same time it has
been reported that visual evidence of healing of a meniscus
requires a 4 month time interval [79]. Therefore, it would
be beneficial if the tissue adhesive remains functional at the
site of application for at least 4 months before it starts to
degrade without rapid loss of its mechanical properties.
Finally, the adhesive strength of the adhesive material
should be sufficient to keep the torn meniscus together
during this period of healing. However, it is hard to
determine what exactly should be the adhesive strength due
to variability of lesions, intended technique to be used and
specificity of each patient’s case. If referred to the
mechanical strength of the currently used devices for
meniscus repair (sutures, stingers, screws), those depend
not only on the device itself but also on the fixation
method.
Rimmer et al. compared the failure strengths of 3
arthroscopic meniscal suturing methods [80]. Depending
on the technique used (a single horizontal loop, a double
vertical loop, and a single vertical loop), the failure
strength was between 29.3 and 67.3 N. Barber et al.
compared the performance of sutures with other surgical
devices [15]. The load to failure was measured of e.g.
double vertical stitch (113 N), single vertical stitch (80 N),
BioStinger (57 N), a horizontal mattress stitch (56 N), a
meniscus arrow (33 N) and the Biomet staple (27 N). It is
evident that the variation in mechanical failure strength is
broad, and the use of a particular method strongly depends
on the individual case, type of lesion and the number of
sutures used. Moreover, it is impossible to directly relate
tensile strength of sutures with the required adhesive
strength of the tissue glue. In studies analysing forces on
sutured menisci (both lateral and medial) in human cadaver
knee models, it was reported that the distraction forces did
not exceed 5 N on average when the applied load was
300 N [81, 82]. In another study, where the distraction
forces were assessed indirectly on bucket-handle lesion, the
occurring forces were determined to be less than 10 N [83].
These forces would correlate to a stress of 50–100 kPa for
a tear measuring 1 cm2, and in the non-weight bearing
recovery period these forces would probably be even
lower. Therefore, tissue adhesives should be designed to
resist physiological stresses and by that stabilize the
meniscus and prevent gap formation [84]. An adhesive
material able to hold a torn meniscus together under a
stress of 50–100 kPa should therefore be already sufficient
for this application.
Another important aspect that should be taken into
consideration in the design of a tissue adhesive for
meniscus repair is the incorporation of cells or growth
factors. These could enhance healing of the meniscus,
especially in the inner a-vascular and a-cellular zone. The
tissue adhesive can serve as a carrier for the molecules,
which can be released on the site of application e.g. via
diffusion process or, if the factors are bound to the glue,
they could be released during degradation of the adhesive.
The beneficial influence of incorporating both cells [85]
and other biological compounds, such as bone marrow or
platelet rich plasma (PRP) [84, 86], on meniscus healing
have been already reported in literature.
A summary of the most important requirements of tissue
adhesives to be used in the repair of meniscus tears is
depicted in Table 1.
85 Page 6 of 18 J Mater Sci: Mater Med (2016) 27:85
123
8 Current developments in the field of tissue
adhesives
Recently, there has been much interest in the research field
of tissue adhesives. Besides a few products which are
already approved for clinical use (e.g. Dermabond, Fibrin
glue, TissuGlu), most research is directed towards the
development of new adhesive biomaterials and improve-
ment of the properties of existing ones.
In general, the biomaterials used for the synthesis of
glues might be composed of natural, synthetic or combi-
nation of both types of polymeric materials [87]. Synthetic
biomaterials are usually cheap and their ground substances
are widely available, the mechanical and physico-chemical
properties might be easy to control, but they can be toxic
and may have a sub- optimal biocompatibility. Natural
materials, on the other hand, offer better biological prop-
erties such as biocompatibility and good cell adhesion, but
the production is more difficult to standardize due to
variability of the ground substances, they are expensive and
carry a risk of disease transmission [88]. In terms of
mechanisms of curing and adhesion to the tissue, the
materials can be divided into several subcategories. Since
numerous reviews were published recently on the chem-
istry and mechanisms of tissue adhesion [89–91], here only
a brief description of the basic mechanisms and examples
from literature are outlined.
8.1 Natural protein-based tissue adhesives
8.1.1 Fibrin adhesives
The most widely used natural tissue adhesive is fibrin glue
(commercially available Raplixa, Artiss, Evarrest, Tisseel).
It is a mixture of fibrinogen and thrombin and its curing
mechanism mimics the final stages of blood coagulation
[77], (Fig. 5a). Fibrin binds to the tissue by three modes:
covalent bonding, hydrogen- and electrostatic bonds and
mechanical interlocking [92]. Other similarly working
adhesives are FloSeal and Proceed (a combination of
bovine thrombin and bovine collagen that form the matrix
for the clot) and CoStasis, which is a combination of
autologous human plasma obtained from patients’ blood
and a mixture of bovine collagen and thrombin. The use of
fibrin gels in meniscal tear repair has been already
described in literature. Ishimura et al. reported results of a
study where meniscal tears of 40 patients using a purified
fibrin glue were repaired [69]. Within the follow up period
of up to 11.4 years post intervention, the rate of recurrence
of tears in the red–red zone or red–white zone was below
10 %, whereas that of tears in the white–white zone was
17 %. In another study, Henning et al. repaired a series of
meniscal tears using an exogenous fibrin clot [47]. It was
reported that in 64 % of cases meniscus was healed. Van
Trommel et al. reported on outside-in repair of a radial tear
of the lateral meniscus using an exogenous fibrin clot in 5
patients. All 5 menisci were found to have healed on fol-
low-up arthroscopy [72]. In a more recent study, Ra et al.
described the use of a fibrin clot together with 2 sutures in
the repair of radial meniscal tears in 12 patients [50].
Follow-up MRI performed after 11 ± 3 months postoper-
atively, revealed complete healing in 11 patients (and
incomplete healing in 1 patient). Also recently, Kamimura
et al. reported the use of fibrin glue together with sutures in
the treatment of degenerative horizontal tears in 18 patients
[93]. The follow-up results of 10 patients showed that
complete healing was achieved in 70 % of cases. Never-
theless, despite successful repair results of meniscal tears
reported in literature, the use of fibrin has not been widely
adopted in clinical practice.
Table 1 Summary of the key requirements of tissue adhesives for meniscus repair
Tissue adhesive Cured adhesive network
Application - Application via syringe/needle (adequate viscosity)
- Can be applied via minimally invasive arthroscopical
procedures
- Easy spreading on the tissue surface (sufficiently hydrophilic),
but does not leak to surrounding tissues
Mechanical
properties
Elastic
modulus
40-
150 MPa
UTS 12-19 MPa
Biodegradation -Starts to gradually degrade
after 4 months of
application
-Degrades to non-toxic, low
molecular weight products
(max 30-50 kDa), which
can be renally excreted
Curing rate -Cures within few minutes after application allowing surgeon to
precisely place it in the tear
Biocompatibility -Does not induce chronic
inflammation
-Non-toxic degradation
products
Adhesive shear
strength
At least 50 kPa
Biocompatibility -Not cytotoxic, does not induce acute inflammatory response
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8.1.2 Gelatine adhesives
Gel-forming mechanisms similar to blood coagulation have
been further investigated.Liu et al. [94] proposed that gelatine
(as a structural protein) and calcium independent transglu-
taminase (mTG) (as a cross-linking enzyme) can be used
(Fig. 5b). They reported that gelatine-mTG adhesives gelate
in situ within few minutes (\5), adhere to tissue in the pres-
ence of blood via covelent bonds (Fig. 5c) and provide suf-
ficient strength to be used as a surgical sealant. Also Chen
et al. investigated the use of gelatine-mTG adhesives [95].
The materials did not induce structural damage of the retina
after injection into the vitreous cavity in rats and their adhe-
sive strength to bovine retinal tissue in vitro was between 15
and 45 kPa. Moreover, peptide-conjugated polymer hydro-
gels formed by tissue transglutaminase cross-linking were
evaluated as an adhesive on guinea pig skin and collagen
membrane [96]. The results show that the adhesive strength to
the tissue was comparable to that of fibrin glue.
Other adhesives of this class are gelatine–resorcinol–
formaldehyde (GRF) and gelatine–resorcinol–formalde-
hyde–glutaraldehyde (GRFG) glues. The gelatine is cross-
linked by aldehyde via reaction with its amine groups. At the
same time, aldehyde groups form covalent bondswith amines
from the tissue. These materials have been utilized in aortic
dissections, liver surgeries, gastrointestinal and urinary track
operations [87]. However, safety issues have arisen regarding
their toxic degradation product—formaldehyde.
8.1.3 Albumin adhesives
In addition, albumin has been investigated as a structural
protein for tissue adhesive compositions. Currently
BioGlue, one such adhesive that comprises bovine serum
albumin (45 %) and glutaraldehyde (10 %) (Fig. 6), is
approved by the FDA for the repair of aortic dissections
[97]. It closes the cavity of the aorta and provides a
stronger arterial wall for its repair, it binds within 30 s and
reaches its maximum bonding strength after 3 min [98].
Although natural protein-based cross-linked adhesives
have excellent biocompatibility, their bonding strength to
the tissue is relatively low, usually in the range of
10–40 kPa. After curing they form networks with the
relatively low mechanical properties of soft hydrogels,
which limit their application in load bearing sites in the
body. Moreover, they are rapidly degraded by enzymes
from the body. Normally they degrade within 2 weeks
[99], which is too fast for meniscus repair. These glues
are however applicable for pulmonary leaks, for
haemostasis in vascular surgery and for treatment of
cerebrospinal leaks.
8.2 Nature-inspired (biomimetic) tissue adhesives
Nature-inspired adhesives, for instance based on glues
secreted by marine sessile organisms (mussels, barnacles,
tube worms), perform very well in hydrated conditions.
The working mechanism is depicted in Fig. 7. Mussels
enzymatically oxidize the phenolic residues of their adhe-
sive proteins. Then, the oxidized residue undergoes a
crosslinking reaction that results in the formation of a
3-dimensional polymeric network. The attachment to the
tissue takes place by bonding to amine and thiol groups
present on the tissue surface [74]. Due to their high adhe-
sion strength and ability to adhere to wet surfaces, these
glues have been proposed for use in biomedical
Fig. 5 a Schematic for fibrin glue cross-linking mechanism [94], b cross-linking mechanism of gelatine with calcium-independent microbial
transglutaminase (mTG) [94], c adhesion mechanism of transglutaminase-cross-linked gelatine to the tissue [146]
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applications. These properties are mainly due to the pres-
ence of a redox functional group: 3,4-dihydroxyphenyl-L-
alanine (DOPA). The key element of DOPA is ortho-di-
hydroxylphenyl (catechol), which exhibits strong affinity
towards organic surfaces [100]. Therefore, development of
biomimetic adhesives have received much attention these
last years and artificial materials that mimic natural forms,
such as co-polypeptides containing DOPA [101], poly
(ethylene glycol) hydrogels and Pluronics functionalized
with DOPA, have been synthesized [102, 103].
Another similar mechanism is present in red and brown
algae, which also, like mussels, excrete phenolic com-
pounds that can bind to both hydrophobic and hydrophilic
surfaces in aqueous conditions. The produced polyphenols
are activated by a vanadate-peroxidase type of enzyme that
allows the cross-linking of the polyphenol with the extra-
cellular carbohydrate fibers, which will finally lead to
adhesion to a surface [104]. Natural algal-borne polyphenol
can be successfully replaced by phloroglucinol. Formula-
tions composed of phloroglucinol, alginate and calcium
ions are capable of adhering to a variety of surfaces
including porcine tissue [105].
One of the strategies to induce a better and stronger
interaction with a surface is the increase of the contact
area. Geckos have used this in an interesting adhesive
strategy that relies on foot pads composed of keratinous
foot-hairs that are split into terminal spatula of a size of
200 nm [106]. The adhesion mechanism is based on
capillary forces and van der Waals interactions. Inspired
by this natural phenomena, Geim et al. developed an
adhesive composed of dense arrays of flexible pillars to
ensure their collective adhesion. However, problems
related to their durability were encountered [107]. To
resolve these problems Lee et al. developed an adhesive
inspired by mussels and geckos, which combine excellent
properties of both mechanisms, and can bind to the sur-
faces both in dry and wet environment in multiple cycles.
The adhesive force in a wet environment was calculated
to be equivalent to 90 kPa [108]. Szomor and Murrel
tested a naturally-sourced glue secreted by Australian
frogs (genus Notaden) on sheep meniscus tissue and
reported that the adhesive strength of this glue (*90 N)
is superior both to fibrin glue (5 times stronger) and
gelatine (2.5 times stronger) [109].
Fig. 6 Cross-linking of a
commercially available
albumin-based adhesive
(BioGlue)
Fig. 7 Working principle of a
mussel adhesive [147]
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Based on recent literature, it can be concluded that
biomimetic tissue adhesives have the potential to be used in
numerous applications. In general, the adhesive strength of
this class of materials is reported to be 20–90 kPa [103,
108, 110]. The cytocompatibility is dependent on the
amount of material added to cells, but in vivo tests showed
no adverse tissue reactions [103]. However, there is almost
no information about degradation profiles of the reported
adhesives and of the mechanical properties of the cured
networks. Therefore, it cannot be indisputably concluded
that these materials could be suitable for treating meniscal
tears.
8.3 Synthetic and hybrid tissue adhesives
Another group of adhesives are polymers, natural, synthetic
or combination of both, whose end-groups have been
modified in a way that allows simultaneous curing and
attachment to the tissue. Examples of this class are
cyanoacrylates, materials containing N-hydroxysuccin-
imide (NHS)- or isocyanate-terminated polymers, as well
as polymers that can be photo cross-linked or those form-
ing networks due to physical interactions e.g. due to ther-
mal gelation.
8.3.1 Cyanoacrylate adhesives
Cyanoacrylate adhesives are very attractive materials for
tissue fixation due to their high bonding strength and ability
to bond in awet environment. The cyanoacrylatesmonomers
polymerize through contact with water (hydroxide ions) or a
weak base, such as cell membranes and tissue [111], (see
Fig. 8). They are applied to the wound site as cyanoacrylate
monomer that undergoes immediate polymerization to form
a polymer film, [112]. However, cyanoacrylates still have
some serious drawbacks for biomedical application. They
degrade reactively in aqueous media with toxic formalde-
hyde as their degradation product [113, 114]. They are brittle
and rigid with the values of elastic modulus in the range of
500–1500 MPa [115]. Additionally, cytotoxic effects may
occur due to oxidative conversion of membranous lipids
[116]. Nevertheless, clinical use of cyanoacrylate adhesives
has been reported as a good replacement for sutures, because
of its better cosmetic effect, reduced pain and recovery
period [117].
Commercially available Dermabond and Histoacryl
are widely used as topical skin adhesives, but they are not
bio-absorbable and therefore in clinical practice they are
used only for skin wounds [97]. Still, the use of His-
toacryl has been compared with sutures in delaying the
formation of a 2 mm meniscal gap [118]. The bovine
menisci were placed in a tensile loading machine and the
force needed for gap formation was measured. The tear was
repaired with either vertical sutures, Histoacryl or both. It
was found that Histoacryl gluing is superior to vertical
sutures regarding gap delaying. However, the best results
were obtained when glue and sutures were used together.
Reckers et al. reported an in vivo study of cyanoacrylate
surgical adhesives used for the fixation of transplanted
menisci in rabbits [119]. It was concluded that the glue
induced necrosis from the cortex to the bone marrow of
transplanted bone surface. In order to improve the bio-
compatibility and mechanical properties of cyanoacrylates,
Lim et al. mixed cyanoacrylate with poly-L-DOPA [120] in
order to improve the physiochemical properties of
cyanoacrylate for use as tissue glue. Lim and Kim also
proposed to mix the cyanoacrylate component with poly(L-
lactide-co-caprolactone) to obtain a biodegradable elas-
tomer [121]. They reported that, although the adhesive
strength was decreased compared to a pure cyanoacrylate
compound, the biocompatibility and flexibility were
improved. This indicates that these materials are more
suitable for specific biomedical applications.
In conclusion, of all known adhesives, cyanoacrylates
are the class of adhesives that form the strongest bond with
tissue. Their adhesive strength values, depending on the
tissue type and type of test performed, are reported to be in
the range of up to a few MPa (30 kPa adhesive strength to
skin up to 2 MPa to bone) [86, 122, 123]. So far, their
toxicity limits their application within the body and they
have been FDA-approved only for topical skin wound
closure. Moreover, their high stiffness (high E modulus),
limits their application in soft tissues, such as meniscus.
8.3.2 Chemically cross-linkable adhesives
In the first class of these materials, the presence of N-
hydroxysuccinimide activates carboxylic groups and
allows them to react with amine groups present on the
surface of the tissues to form amide bonds. In contrast, an
Fig. 8 Schematic illustrating
the polymerization principle of
cyanoacrylates
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unactivated carboxylic acid group would just lead to salt
formation with an amine. Strehin et al. characterized
chondroitin sulphate-PEG adhesive hydrogels (CS-PEG),
which covalently adhere to tissue through an amide bond.
CS-NHS was mixed with PEG-(NH2)6 to tune
hydrophilicity and the molecules react to form a hydrogel,
but at the same time, CS-NHS also reacts with tissue [124],
see Fig. 9a. Simson et al. described an adhesive hydrogel
composed of a mixture of bone marrow aspirate and
chondroitin sulphate end-functionalized with NHS to bind
and stabilize the interface of bovine meniscus tissue [84].
The results showed that the adhesive strength to meniscus
was in the range of 60–335 kPa, which should be enough to
keep a torn meniscus together. Moreover, the viability and
proliferation of fibrochondrocytes was positively influ-
enced by the glue. Therefore, it was concluded that this
system could be used to mechanically stabilize a tear and
stimulate regeneration of the tissue across the injury site.
Taguchi et al. [125] investigated biodegradable adhe-
sives composed of human serum albumin (HSA) and
organic acid-based cross-linkers (trisuccinimidyl citrate,
disuccinimidyl tartarate (DST) and disuccinimidyl malate)
with activated NHS groups. The best results were obtained
using DST. The adhesive strength of these biocompatible
and bioresorbable materials was better than that of fibrin
glue. The active ester groups present in DST react with the
amine groups from HAS and collagen molecules from the
tissue. The adhesive composed of DST/HSA was evaluated
in the gluing of meniscal tears [126]. Glued and sutured
porcine menisci were implanted subcutaneously in rabbits,
and after 3 months, tensile tests and histology were done.
Comparisons were made between tears treated with
sutures, tears treated with sutures soaked with adhesive and
tears treated with only adhesive. The results showed best
performance when the sutures were soaked with adhesive
(*70 N), followed by sutures (*61 N) and adhesive
(*60 N) only. This indicates the potential of this class of
materials in meniscal repair.
Adhesives comprising isocyanate-terminated molecules
have a similar bonding mechanism. They form a covalent
bond with the tissue and cure to form polyurethane net-
works upon contact with the surrounding fluids [127], see
Fig. 9 a Scheme of the adhesion and network formation mechanism
of CS-PEG hydrogels. These hydrogels attach via covalent bonding of
the NHS-activated carboxyl groups to the amine groups of the tissue
(reprinted from [124]). b Scheme of the attachment of isocyanate-
terminated polymer molecules to the surface of the tissue by covalent
bonding and the formation of a polymer network by cross-linking
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Fig. 9b. Compared with other biomaterials, polyurethanes
possess many advantages, such as high tenacity, toughness,
water and chemical resistance and mechanical flexibility
[128]. Biodegradable polyurethanes are designed to
undergo (enzymatic) hydrolytic degradation to non-cyto-
toxic products [129]. Mostly aliphatic diisocyanates are
used in the design of biomaterials intended for biomedical
use, since it has been shown that they exhibit lower toxicity
comparing to aromatic ones [130].
Hadba et al. described the development of two compo-
sitions of branched isocyanate-functional adhesives based
on poly(ethylene glycol) and adipic acid functionalized
with 2,4-toluene diisocyanate (TDI) or 4,40-methylene-
bis(phenyl isocyanate) (MDI) [131]. The adhesive strength
of the formulated materials to porcine stomach tissue
depended on the specific formulation, the highest value
determined was approximately 100 kPa (1093 gf/cm2).
Rohmet al. and Sternberg et al. [116, 132] reported the use
of mixtures of 1,2-ethylene glycol bis-(dilactic acid) func-
tionalized with hexamethylene diisocyanate (HDI) with
different biodegradable polymers such as hyaluronic acid,
gelatin, chitosan acetate and chitosan chloride. The obtained
products had promising properties in terms of biodegrad-
ability, biocompatibility and adhesive strength (which was
similar or better than fibrin glue). The solidification speed
could be adjusted by using aqueous solution of chitosan
chloride as a second component of the adhesive system.
Nayeb-Habib et al. developed a isocyanate pre-polymer
and chitosan gel based tissue adhesive in order to combine
good adhesion of isocyanates and biocompatibility and
healing properties of chitosan [133]. Degradation products
of this polymer did not induce any toxicity. Field et al.
evaluated two isocyanate-based adhesives to repair full
thickness meniscal wounds in an ovine model in vivo over
a period of 1 month [134]. A 10 mm defect in the medial
meniscus was repaired with these adhesives, and after
1 month signs of repair and tissue regeneration were
observed and no adverse inflammatory reaction was pre-
sent. Nevertheless, despite the progress in the development
of less toxic materials with suitable mechanical properties
and satisfactory curing times, until today there is only one
isocyanate-based tissue adhesive commercially available:
TissuGlu (Cohera Medicals Inc). It is FDA-approved for
use in abdominoplasty surgery.
8.3.3 Photo cross-linkable adhesives
Another interesting class of tissue adhesives are those that
are photo cross-linkable, an example is commercially
available FocalSeal. It is a copolymer composed of
hydropihilic polyethylene glycol (PEG), and glycolide or
lactide, trimethylene carbonate and acrylic acid moieties.
These materials are crosslinked by light, which also
initiates their adhesion to tissue [135]. The acrylate groups
covalently bind to the amine groups of the tissue and form
an interpenetrating network upon curing. The material is
biodegradable; resorption takes approximately 3 months
[97]. The application process, however, is complicated
because delivery of a source of curing light to the appli-
cation site can be technically difficult.
In another study Lang et al. developed acrylate-func-
tionalized copolymers based on sebacic acid and glycerol
that could be cross-linked with light [136]. The materials
were used in vivo to attach a polymeric patch to the beating
heart of rats and pigs. The patch remained in place even
under higher than normal heart beat rates.
Ishihara et al. [137] worked on chitosan derivatives that
could be crosslinked with UV light. The chitosan hydrogel
obtained could stop bleeding from a cut mouse tail and keep
two pieces of sliced mouse skin together. Moreover, appli-
cation of the chitosan hydrogel induced significant wound
contraction and accelerated wound closure and healing.
In a recent study by Jeon et al. a light-activated adhesive
based on mussel proteins and insect dityrosine crosslinking
chemistry is reported [138]. The adhesive could be easily
photo-cross-linked using visible light, the adhesion and
cross-linking mechanism is depicted in Fig. 10. The
adhesive strength to porcine skin was around 50 kPa, and
no adverse tissue response after closing incisions on the
back of rats was observed.
8.3.4 Thermo-responsive adhesives
A different group of materials are those, which can be
cross-linked physically. Lando et al. and Cohn et al.
developed an interesting approach, in which thermo-re-
sponsive biodegradable copolymers based on lactide-e-
caprolactone and three-armed trimethylolpropane-lactide-
e-caprolactone were used as tissue adhesives [139, 140].
These low molecular weight materials were in a flow state
with low viscosity at the temperature of application and
could attain high viscosity at the body temperature. The
adhesive failure strength to polyamide (6,6-nylon) films,
which was used as a model for a tissue, was measured to be
up to 2 N/cm width of the film.
Although chemically modified tissue adhesives hold
great potential for use in a variety of medical applications,
further studies are required to develop materials for specific
applications such as the treatment of meniscus tears.
8.4 Formulation of tissue adhesives with biological
factors
It has been recognized that incorporation of biological
molecules, growth factors, platelet rich plasma (PRP), bone
marrow (BM) and living cells to the adhesive can enhance
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healing of the tissue [86]. Ishimura et al. reported an
experimental study in which they incorporated marrow
cells into fibrin gel and compared the healing rate of the
torn meniscus with fibrin gel that did not contain cells [85].
The results showed faster and more mature healing of
defects in the group, which contained marrow cells. A
similar approach was used by Scotti et al.: To improve the
bonding between two swine meniscal slices, articular
chondrocytes were added to a fibrin glue gel. The bonding
capacity was evaluated in a nude mouse model after
implantation for 4 weeks [141]. The results showed firm
gross bonding in the experimental samples, while no
bonding was observed in the control samples that did not
contain cells. Although the success of this approach has
only been described in a limited number of studies, the
very promising results obtained justify the further investi-
gation of cell-containing adhesives for meniscus repair.
9 How do tissue adhesives compare
with the requirements for repair of the damaged
meniscus and the current gold standard
treatment?
The most important prerequisites for a tissue adhesive to be
suitable for meniscus tear repair include: adequate
mechanical properties; suitable degradation profile, suffi-
cient adhesive strength, short curing times and good bio-
compatibility (see Table 1). Comparing these requirements
with the properties of the tissue adhesives described above,
it can be concluded that up to now no tissue adhesive
material has yet been developed that fully complies with all
requirements. However, this not only due to sub-optimal
properties of the adhesives, such as insufficient bonding
strength in the case of enzymatically cross-linked adhe-
sives or poor biocompatibility in the case of cyanoacry-
lates. It is also due to lack of the data that is required to be
able to conclude if a certain material is suitable for the
intended application. Simson et al., for example, described
a promising bone marrow-chondroitin sulphate tissue
adhesive for meniscus repair, however no information
regarding its biodegradability was presented.
Moreover, although lap shear adhesion tests are one of
the most often employed methods to assess the adhesive
strength of newly developed glues, the conditions under
which these tests are conducted are not standardized. There
have been many substrates and tissue models used to
evaluate the adhesion strength of tissue adhesives, e.g.
polyamide films [139, 140], gelatin pieces [142–144],
collagen membranes [96], and even pig skin and wood
[73]. Additionally, very different environments (wet or
dry), gluing temperature and the curing times have been
used. These large variations make direct comparison of the
outcomes of described experiments difficult.
Up to now, there have been only few clinical studies
reporting the use of tissue adhesives in the repair of
meniscal tears, all studies involved fibrin glue. As this
particular adhesive has poor mechanical- and adhesive
properties, it cannot be used as to replace the use of sutures
as gold standard. There is much interest in the development
Fig. 10 Network formation of a tissue adhesive with visible light using dityrosine groups (reprinted from [138])
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of new adhesive materials. However, more systematic
(clinical) research is needed before the suitability of a
newly developed tissue adhesive for the intended applica-
tion can be proven.
10 Conclusions
Among the methods currently used to repair meniscus, the
ideal solution has not yet been found. Tissue adhesives
hold great potential to replace or support sutures and sta-
ples. Many new adhesive materials with a good prognosis
for use in a variety of applications have been developed.
However, most of them have not been sufficiently char-
acterized to be able to qualify them as being suitable for
meniscus repair. Nevertheless, chemically cross-linked
adhesives seem the most versatile as these are based on
existing natural or synthetic polymers and can be readily
modified. Their properties can be adjusted by careful
molecular design and chemical functionalization to make
them suitable for the intended application.
Standardized relevant biomechanical and biological
models need to be defined to compare different available
and developed tissue adhesives, and to be able to address
their suitability for the repair of meniscal tears. In clinical
practice, the most successful treatment modality remains
the use of sutures. Nevertheless, there is great need for a
suitable meniscus tissue adhesive. Such adhesive should be
easily applied in a meniscal tear, bind strongly to meniscal
tissue, hold the torn region together, facilitate its healing,
and then gradually degrade into non-toxic products.
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